top of page
business-partners-handshake-global-corporate-with-technology-concept.jpg
Merlinn EPD Transparent 3.png
Image by Thought Catalog

Turning NHS EPD Data into Actionable Insight

Merlinn, offers the clearest public signal of true prescribing behaviour in England. By embedding NHS England Prescription Data (EPD) into Merlinn, this public dataset is transformed into a strategic advantage for pharmaceutical manufacturing and distribution efficiency.​​

​

Merlinn is a easy-to-use analytics and reporting platform designed for exploring NHS prescribing data with the latest technology. It allows each organisation to work only with the molecules and data segments that matter to them.

With no need for infrastructure, maintenance, technical teams or operational overhead, companies can access all relevant prescribing information on the same day through a simple subscription.


Merlinn also supports detailed pricing and behavioural analysis to help teams understand prescribing dynamics clearly. Its capabilities are designed for a wide range of roles, enabling BD, manufacturing, commercial excellence, sales and other teams to work confidently with transparent, structured insight.

Subscription Options

Trial Subscription

£ 350/Week

For Companies that want to try it for a limited time

  • Data Available at Chemical Level

  • Min 5 Chemicals

  • Customers may Purchase additional bundles of 5 Chemicals

7051467.png

Green Subscription

ASK FOR PRICE

For Companies with Broader Portfolios

  • Data Available at Chapter level  (data of 1 Chapter include arround 60 -120 chemicals)

  • Min 1 Chapter

  • Includes Region, ICB, PCO, City and Surgery-level insights.

  • 2 Users Included

  • ​BD Module is not included

medical-healthcare-background_edited_edi

Yellow Subscription

£ 1.250/Month

For Companies with Smaller Portfolios

  • Data Available at Chemical Level

  • Min 5 Chemicals

  • Includes Region, ICB, PCO, City and Surgery-level insights.

  • Customers may Purchase additional bundles of Chemicals

  • 1 User Included, additional users £360 per .

  • ​BD Module is not included

  • VAT is not Included

e7e2921f-4aed-4ef8-a805-030a46cac9e4.png

Blue Subscription

ASK FOR PRICE

For Full Market Analysis

  • Full market access across all Chapters. (21 Chapter, 1.650 Chemical )

  • Includes Region, ICB, PCO, City and Surgery-level insights.

  • 2 Users Included

  • ​BD Module is not included

11171.jpg
ChatGPT Image Oct 7, 2025, 05_35_22 PM.png

Merlinn Business Development (BD) Module

Merlinn provides a structured way to simulate, evaluate and refine ideas using transparent NHS prescribing data.
Beyond Business Development, the module supports manufacturing, commercial excellence and sales teams by enabling Manufacturing and Sales and distribution scenarios.
Expanded portfolio scenarios reveal molecules where strengthened competition may improve NHS access, affordability and overall system efficiency.

Subscription Options

Blue Subscription + BD Module

  • Full market access across all Chapters. (21 Chapter, 1.650 Chemical )

  • Includes Region and City-level insights.

  • + BD Modules

  • ​2 users included

Standalone BD Suite

  • Available as a standalone product or as an add-on to any panel.

  • Specially Developed Molecule Segmentation.

  • Pricing and revenue impact scenarios.

  • Manufacturing optimization and supply chain risk simulations.

  • 1 user included

Green Subscription + BD Module

  • Access at Chapter level (includes data of 1 Chapter).

  • Includes Region and City-level insights.

  • Specially Developed Molecule Segmentation.

  • +BD Module (Chapter molecules)

  • 2 users included

Amber Panel

  • Everything to decide to come to the UK

  • Molecule Segmentation

  • Grow your business scenario

  • Molecule Sales Report by Geo

  • Reach to Consultancy Supplier for Regulations, Legal and Business

bottom of page